Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
Recruiting · NCT06892145 · Registry updated 2025-12-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 | 2025-12-22 | NCT06892145 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 34 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 561 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) | Hefei | China | 5 |
| the Second Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou | China | 29 |